Navigation Links
Clinimetrics Celebrates 20th Anniversary in Contract Research Business
Date:1/22/2008

SAN JOSE, Calif., Jan. 22 /PRNewswire/ -- Clinimetrics today announced a major milestone -- 20 years in business as a leading contract research organization (CRO) with a particular emphasis on the development needs of biotechnology and early stage pharmaceutical and medical device companies.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010215/CLINIMETRICSLOGO)

Brad Zaro, founder and CEO of Clinimetrics, commented, "During the past two decades, we have seen significant growth and success. Today we have a solid team of clinical research professionals that allows us to provide a full complement of services to benefit our customers. We look forward to continuing our growth in the CRO business, where a long legacy of service performance is important."

Since 1988, Clinimetrics has worked with over 160 clients throughout the world, and has successfully enabled clients to complete more than 1,000 clinical projects (Phases I-IV), in a wide range of therapeutic areas. Clinimetrics, an Omnicare, Inc., company, offers an array of integrated research services including clinical and data management, electronic data capture via Oracle(TM) RDC, project management and biostatistics, as well as quality assurance, regulatory and medical affairs. In addition, Clinimetrics provides in-house staffing, customized training programs, and integrated travel and event planning services. Clinimetrics is headquartered in San Jose, California, and has offices in Atlanta, San Diego, and Toronto.

For more information, please visit our website: http://www.clinimetrics.com.

Contact: Matt Smith

Phone: 408-452-8215


'/>"/>
SOURCE Clinimetrics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Baxter Kidney Patient Education Program Celebrates Tenth Anniversary
2. Aware Celebrates Fifteen Years of Innovation and Leadership in the Biometrics Industry
3. MedImmune Celebrates Opening of New Pilot Lab at Gaithersburg Headquarters
4. The Parkinsons Disease Foundation Commemorates its 50th Anniversary with Special Scientific Symposium on Parkinsons Disease
5. Kendle Marks 10th Anniversary as Public Company With NASDAQ Opening Bell Ceremony and Investor Day Event
6. Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA
7. Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format
8. HealthTrust Expands Contract With Instrumentation Laboratory for Critical Care Portfolio to Include Consorta
9. Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program
10. The Tauri Group LLC Awarded U.S. Department of Homeland Security Chemical and Biological Early Detection Systems Program Office Support Contract
11. EDS Awarded $715 Million Contract for Bristol-Myers Squibb Information Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Antonio, TX (PRWEB) August 29, 2014 ... and ISO 13485:2003 certified, GAMP® 5 compliant imaging ... awarded an international Phase II clinical trial to ... lymphoma. , Throughout this trial, Intrinsic Imaging will ... not limited to, protocol and charter development, site ...
(Date:8/28/2014)... 2014 Best Sanitizers, Inc., the first ... hand sanitizer, asks food processors and food handling professionals ... sanitizer they’re currently using to Best Sanitizers’ Alpet® ... critical to fighting cross-contamination and the spread of pathogens ... there are key criteria that make a hand sanitizer ...
(Date:8/28/2014)... are important devices in spintronics, an electronic which ... electrons but also on their spin and the ... electric into magnetic signals and vice versa. Recently, ... the Institute of Physics at Johannes Gutenberg University ... Prague, and Japan, has for the first time ...
(Date:8/28/2014)... month, executives from clinical trial marketing firm BBK Worldwide will ... Patient-Centered Clinical Trials 2014 , to be held at the ... 4-5. Patient recruitment experts Bonnie A. Brescia , ... insights on the benefits of employing an effective patient engagement ... to mobile apps – can be used to drive study ...
Breaking Biology Technology:Intrinsic Imaging Awarded Phase II Clinical Trial to Assess New Treatment for Non-Hodgkin’s Lymphoma 2Food Processors and Food Handlers are Encouraged to Prepare for Fall Harvest by Evaluating Their Current Hand Sanitizer Using Nine Key Criteria 2Food Processors and Food Handlers are Encouraged to Prepare for Fall Harvest by Evaluating Their Current Hand Sanitizer Using Nine Key Criteria 3A new, tunable device for spintronics 2A new, tunable device for spintronics 3BBK Worldwide Leads Sessions at Key September Events 2
... Anesiva,Inc. (Nasdaq: ANSV ) announced today the ... of its common stock at $4.05 per share, ... on December 12, 2007, for,approximately $45 million in ... $50 million if the underwriters,over-allotment option described below ...
... 13 Synosia Therapeutics today,announced the appointment of ... officer, effective immediately., Dr Blanc, who will ... joins from Syngenta, where he created and led ... and an,experienced biotech entrepreneur, Dr. Blanc helped biotech ...
... Neurocrine Biosciences,Inc. (Nasdaq: NBIX ) announced today ... webcast to provide an update on indiplon Thursday,morning, December ... a.m. Eastern,Time (6:00 a.m. Pacific Time)., Participants can ... 785-424-1071 (International) using the conference,ID: NEURO12. The call can ...
Cached Biology Technology:Anesiva Raises $45 Million in Common Stock Offering 2Synosia Therapeutics Announces Appointment of Chief Business Officer 2
(Date:8/31/2014)... Montral, August 31, ... Nature Neuroscience journal by, Sylvain Williams, PhD, and his ... University Institute and McGill University, opens the door towards better ... as well of the role of an essential element of ... In 2009, they developed a unique approach namely, the ...
(Date:8/29/2014)... Until recently, little has been known about what genetic ... team of scientists, one of whom is a University ... showing that genes controlling the development of the brain ... domestication., The study was published Aug. 28 in ... It is online at http://www.sciencemag.org/ ., The domestication ...
(Date:8/29/2014)... the type and number of connections in transcription factor ... robustness in a study published in PLOS Computational ... the assortativity signature contributes to a network,s resilience against ... the out-out assortativity of TFN models has a greater ... three types of assortativity," said Dov A. Pechenick, PhD, ...
Breaking Biology News(10 mins):Memory and Alzheimer's: Towards a better comprehension of the dynamic mechanisms 2New research reveals how wild rabbits were genetically transformed into tame rabbits 2New research reveals how wild rabbits were genetically transformed into tame rabbits 3Assortativity signatures of transcription factor networks contribute to robustness 2
... MADISON Failing to see the forest for ... declining health of Wisconsin,s forest ecosystems. Even areas ... as forests are increasingly fragmented by roads and development, ... fields, housing tracts, and strip malls, say University of ...
... rings are acclaimed in representing natural climate archives. ... growth of these annual rings depend mainly on temperature ... slight seasonal variations, the correlation is not so ... for Geosciences and their colleagues of the Australian National ...
... Versartis, Inc., an emerging company developing novel biologics ... presented data for its long-acting product candidates, VRS-317 (hGH-rPEG) ... (IL-1ra-rPEG) for treatment of type 1 and type 2 ... DC. Versartis, through a unique licensing agreement with Amunix, ...
Cached Biology News:Isolated forest patches lose species, diversity 2Isolated forest patches lose species, diversity 3Australia's climate: Drought and flooding in annual rings of tropical trees 2Versartis presents positive preclinical data on 2 product candidates at ENDO 09 2
EDG-1 Western blot control Source: Cell Lysate Application: Western Blotting Control...
Complete cell culture media with cytokines...
...
BD IMagnet 1 each...
Biology Products: